Archives

  • 2026-09
  • 2026-08
  • 2026-07
  • 2026-06
  • 2026-05
  • 2026-04
  • 2026-03
  • 2026-02
  • 2026-01
  • 2025-12
  • 2025-11
  • 2025-10
  • 2025-09
  • 2025-08
  • 2025-07
  • 2025-06
  • HyperFluor™ 488 Goat Anti-Human IgG (H+L) Antibody: Mecha...

    2026-01-21

    HyperFluor™ 488 Goat Anti-Human IgG (H+L) Antibody: Mechanism, Benchmarks, and Immunoassay Integration

    Executive Summary: The HyperFluor™ 488 Goat Anti-Human IgG (H+L) Antibody (SKU K1205, APExBIO) is a polyclonal secondary antibody conjugated to Alexa Fluor 488, enabling high-sensitivity detection of human immunoglobulins in immunoassays (APExBIO product page). Its excitation/emission maxima are 495/519 nm, compatible with standard FITC filter sets. The antibody is affinity-purified for specificity and minimal cross-reactivity, with validated use in Western blot, immunofluorescence, IHC, flow cytometry, and ELISA workflows (Lu et al., 2024). Signal amplification is achieved by multiple secondary antibodies binding to each primary, increasing assay sensitivity. Proper storage (4°C short term; –20°C long term) and protection from light preserve functional performance.

    Biological Rationale

    The detection of human immunoglobulins is foundational in immunological and translational research. Secondary antibodies targeting the Fc and light chain (H+L) regions of human IgG enable versatile detection across a variety of immunoassays (see comparative use cases). Alexa Fluor 488 is a bright, photostable fluorochrome with excitation at 495 nm and emission at 519 nm, providing compatibility with standard fluorescence detection platforms (Thermo Fisher, Alexa 488 datasheet). The use of polyclonal goat antibodies ensures recognition of multiple epitopes on human IgG, increasing detection robustness and reliability. Signal amplification through secondary antibody binding is essential for detecting low-abundance targets, particularly in translational vaccine research where immune response quantification is critical (Lu et al., 2024).

    Mechanism of Action of HyperFluor™ 488 Goat Anti-Human IgG (H+L) Antibody

    The HyperFluor™ 488 Goat Anti-Human IgG (H+L) Antibody operates via specific recognition of the constant regions of human IgG heavy and light chains. The antibody is generated in goats and affinity-purified using human IgG antigen-coupled agarose beads, minimizing cross-reactivity (APExBIO). Alexa Fluor 488 is covalently conjugated to the antibody, enabling sensitive fluorescence-based detection. Upon incubation with samples containing human IgG (e.g., tissue sections, cell lysates, plasma), the secondary antibody binds to primary human IgG antibodies, allowing visualization or quantitation via fluorescence readout.

    Multiple secondary antibodies can bind to a single primary antibody, enhancing signal intensity (signal amplification). This is particularly beneficial for applications such as Western blotting, immunofluorescence, and flow cytometry, where detection sensitivity can be a limiting factor. The buffer formulation (23% glycerol, PBS, 1% BSA, 0.02% sodium azide) ensures protein stability, reduces background, and preserves fluorescence during storage and use. The antibody is supplied at 1 mg/mL and should be aliquoted and stored at –20°C for extended periods, avoiding repeated freeze-thaw cycles and light exposure.

    Evidence & Benchmarks

    • Alexa Fluor 488 conjugation enables detection at excitation/emission maxima of 495/519 nm, compatible with standard FITC filter sets (Thermo Fisher datasheet).
    • Affinity purification using antigen-coupled agarose beads results in high specificity and minimal cross-reactivity in human immunoglobulin detection (APExBIO).
    • Signal amplification is achieved by multiple secondary antibodies binding per primary antibody, increasing sensitivity in ELISA, Western blot, and immunofluorescence (internal review).
    • Use of this secondary antibody facilitated robust detection of anti-SARS-CoV-2 IgG responses in vaccine preclinical models (Lu et al., 2024, DOI).
    • Storage at 4°C for ≤2 weeks or –20°C for ≤12 months maintains antibody stability and fluorescence integrity (APExBIO).

    Applications, Limits & Misconceptions

    The HyperFluor™ 488 Goat Anti-Human IgG (H+L) Antibody is validated for use in:

    • Immunocytochemistry/Immunofluorescence (ICC/IF)
    • Western blotting (WB)
    • Immunohistochemistry on frozen (IHC-Fr) and paraffin-embedded tissues (IHC-P)
    • Flow Cytometry (Flow Cyt)
    • Enzyme-Linked Immunosorbent Assay (ELISA)

    These applications are routinely deployed in translational and preclinical immunology. For example, in SARS-CoV-2 vaccine studies, detection of anti-spike IgG responses via fluorescent secondary antibodies provides a rapid, quantitative readout (Lu et al., 2024).

    This article extends the scenario-driven solutions outlined in Scenario-Driven Solutions with HyperFluor™ 488 Goat Anti-Human IgG by providing deeper mechanistic and benchmark data relevant for high-throughput and translational workflows.

    Common Pitfalls or Misconceptions

    • Not for direct detection of non-human IgG: This antibody is specific to human IgG; it does not reliably detect rodent or other species’ immunoglobulins.
    • Photobleaching risk: Alexa Fluor 488, while photostable, will degrade under prolonged light exposure. Always protect from light during storage and use.
    • Cross-reactivity with endogenous immunoglobulins: In human tissue samples, high background may occur if endogenous IgG is not adequately blocked.
    • Not suitable for live-cell applications: Sodium azide in the storage buffer is cytotoxic; do not use in live-cell imaging or assays.
    • Repeated freeze-thaw cycles reduce performance: Always aliquot to minimize degradation.

    Workflow Integration & Parameters

    Integration of the HyperFluor™ 488 Goat Anti-Human IgG (H+L) Antibody into immunoassays involves several critical parameters:

    • Concentration: Supplied at 1 mg/mL; typical working dilutions range from 1:200 to 1:1,000 depending on application and signal strength required.
    • Buffer composition: 23% glycerol, PBS, 1% BSA, 0.02% sodium azide to ensure stability.
    • Storage: 4°C for up to two weeks; –20°C (aliquoted) for up to 12 months. Avoid light and repeated freeze-thaw cycles.
    • Detection: Optimal with filter sets matching Alexa Fluor 488’s 495/519 nm excitation/emission properties.

    For practical troubleshooting and advanced workflow strategies, see Optimizing Immunoassays with HyperFluor™ 488, which this article expands by detailing performance parameters and cross-platform integration.

    Researchers conducting multiplexed or high-throughput assays should calibrate for background fluorescence and titrate antibody concentrations to optimize signal-to-noise ratio. APExBIO recommends avoiding sodium azide-containing buffers during peroxidase-based detection steps, as azide can inhibit enzymatic activity.

    Conclusion & Outlook

    The HyperFluor™ 488 Goat Anti-Human IgG (H+L) Antibody from APExBIO represents a benchmark reagent for sensitive, specific detection of human immunoglobulins in diverse immunoassays. Its validated performance, robust signal amplification, and compatibility with standard fluorescence platforms make it suitable for translational, clinical, and basic research. Ongoing advances in vaccine and immunotherapy research, such as preclinical SARS-CoV-2 studies (Lu et al., 2024), continue to benefit from the reliability of this fluorescent secondary antibody. For extended guidance on advanced applications and troubleshooting, see our linked review, which this article updates with latest mechanistic and benchmarking data.

    For product details and ordering, visit the HyperFluor™ 488 Goat Anti-Human IgG (H+L) Antibody product page.